Phytosterols Market Report 2026

The phytosterols market size has grown rapidly in recent years. It will grow from $1.2 billion in 2025 to $1.34 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing consumer awareness of cardiovascular health, growth of functional food consumption, rising demand for natural bioactive ingredients, expansion of nutraceutical manufacturing capacity, availability of plant-derived sterols.

The phytosterols market size is expected to see rapid growth in the next few years. It will grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to increasing prevalence of lifestyle-related diseases, rising demand for preventive healthcare nutrition, expansion of clean-label food products, growing investments in functional ingredient innovation, increasing adoption of phytosterols in animal nutrition. Major trends in the forecast period include rising demand for cholesterol-lowering functional ingredients, increasing use of phytosterols in fortified foods, growing adoption in dietary supplement formulations, expansion of plant-based bioactive compounds, enhanced focus on heart health nutrition.

The increasing prevalence of cardiovascular disease is significantly contributing to the growth of the phytosterols market going forward. Cardiovascular disease is a general term encompassing conditions affecting the heart or blood vessels, including coronary heart disease, stroke, peripheral arterial disease, aortic disease, and other conditions. Plant sterols, or phytosterols, compete with cholesterol absorption by binding to micelles and lowering cholesterol concentration. Daily consumption of phytosterols is associated with an 8% to 10% reduction in LDL cholesterol levels. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, accounting for approximately one in every three deaths. Therefore, the increasing prevalence of cardiovascular disease is driving the growth of the phytosterols market.

Major companies operating in the phytosterols market are focusing on developing new products and solutions to sustain their market position. For instance, in May 2023, ProBiotix Health PLC, a UK-based life sciences company, launched CholBiome CH, an innovative dual-action cholesterol-reducing bi-layer tablet. Lactobacillus plantarum LPLDL and plant sterols/stanols (PSS) are the two active ingredients of the tablet. These work in combination to lower both internal and dietary cholesterol levels. The LPLDL component produces enzymes that break down bile salts, encouraging the liver to eliminate cholesterol from the blood while maintaining bile salt balance. This allergen- and GMO-free innovation delivers a dual mode of action for effective cholesterol management.

In October 2023, Kensing LLC, a US-based specialty materials company, acquired Advanced Organic Materials for an undisclosed amount. With this acquisition, Kensing LLC aims to expand its portfolio of high-performance organic materials, enhance research and development capabilities, strengthen its market position in advanced material solutions, and drive long-term growth across industrial and commercial applications. Advanced Organic Materials is an Argentina-based company specializing in the development and supply of innovative organic compounds and specialty materials.

Major companies operating in the phytosterols market are BASF SE, Cargill, Incorporated, Archer Daniels Midland Company, Wilmar International Limited, DSM-Firmenich AG, Kerry Group plc, Ingredion Incorporated, Ashland Global Holdings Inc., Bunge Limited, Corbion N.V., AAK AB, Fuji Oil Holdings Inc., Matrix Fine Sciences Pvt. Ltd., Raisio plc, Vitae Naturals Inc., Arboris LLC, Gustav Parmentier SAS, COFCO Group, Sohar Nutrition LLC, Cognis GmbH.

Europe was the largest region in the phytosterols market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phytosterols market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the phytosterols market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The phytosterols market consists of sales of brassicasterol, campestanols, sitostanols, and cycloartenol. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.